Diagnostic misconceptions? A closer look at clinical research on Alzheimer's disease

Journal of Medical Ethics

Volumn 38, Issue 1, 2012, Pages 57-59

  Kutschenko, Lara K ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; DISEASE COURSE; EARLY INTERVENTION; ETHICS; HUMAN; MEDICAL RESEARCH; METHODOLOGY; PATIENT SELECTION; RESEARCH ETHICS;

ALZHEIMER DISEASE; BIOMEDICAL RESEARCH; DISEASE PROGRESSION; EARLY MEDICAL INTERVENTION; ETHICS, RESEARCH; HUMANS; PATIENT SELECTION; RESEARCH DESIGN;

EID: 84856769934     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2011-100026     Document Type: Article

References (25)

1. Mangialasche F, Solomon A, Winblad B, et al. Alzheimer's disease: clinical trials and drug development. Lancet Neurol 2010;9:702-16.
2. Alzheimer's Association. About Alzheimer's Association TrialMatch™. http://www.alz.org/research/clinical_trials/find_clinical_trials_trialmatch.asp (accessed 17 May 2011).
3. Nuffield Council on Bioethics. Chapter 8-Research. In: Nuffield Council on Bioethics Dementia: Ethical IssuesdSummary of Public Consultation. London: Nuffield Council on Bioethics, 2009:128-42.
4. Petersen RC. Mild cognitive impairment: current research and clinical implications. Semin Neurol 2007;27:22-31.
5. Cartwright N. Evidence-based policy: what's to be done about relevance? Philos Stud 2009;143:127-36.
6. Jelic V, Kivipelto M, Winblad B. Clinical trials in mild cognitive impairment: lessons for the future. J Neurol Neurosurg Psychiatry 2006;77:429-38.
7. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-9.
8. Canguilhem G. The Normal and the Pathological. New York: Zone Books, 1989.
9. Paul NW. A closer look at health and disease as prerequisites for diagnosis and prognosis. Med Stud 2010;2:95-100.
10. Shineman DW, Salthouse TA, Launer LJ, et al. Therapeutics for cognitive aging. Ann NY Acad Sci 2010;1191:E1-10.
11. Bonah C, Rasmussen A, Massutti C, eds. Harmonizing Drugs. Standards in 20th Century Pharmaceutical History. Paris: GLYPE, 2009.
12. Balz V. Zwischen Wirkung und Erfahrung. Eine Geschichte der Psychopharmaka. Neuroleptika in der Bundesrepublik Deutschland, 1950-1980. Bielefeld: Transcript, 2010.
13. Gradmann C, Simon J, eds. Evaluating and Standardizing Therapeutic Agents, 1890-1950. Basingstoke: Palgrave Macmillan, 2010.
14. Joffe S, Miller FG. Bench to bedside: mapping the moral terrain of clinical research. A clinical trial is purely science, not medical care. Hastings Cent Rep 2008;38:30-42.
15. Kimmelman J, London AJ. Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. Plos Med 2011;8:e1001010.
16. American Psychiatric Association. Dementia, Amnestic, OtherCognitive.aspx. DSM-5 Development. DSM-5 Neurocognitive Criteria, 2010. http://www.dsm5.org/ProposedRevisions/Pages/Delirium (accessed 15 Oct 2010).
17. Ten Have H. Medical technology assessment and ethics ambivalent relations. Hastings Cent Rep 1995;25:13-19.
18. Conrad P. The medicalization of society. In: On the Transformation of Human Conditions into Treatable Disorders. Baltimore: Johns Hopkins University Press, 2007.
19. Hacking I. Kinds of people: moving targets. Proc Br Acad 2007;151:285-318.
20. Huber L. Imaging the brain-'visualising pathological entities'? Searching for reliable protocols within psychiatry and their impact on the understanding of psychiatric diseases. Poiesis Prax 2009;6:27-41.
21. Dumit J. Is it me or my brain? Depression and neuroscientific facts. J Med Hum 2003;24:35-47.
22. Lock M, Nguyen V-K. Genomics, epigenomics, and uncertain futures. In: Lock M, Nguyen V-K, eds. An Anthropology of Biomedicine. West Sussex: Blackwell Publishing, 2010.
23. Appelbaum PS, Roth LH, Lidz CW. The therapeutic misconception: informed consent in psychiatric research. Int J Law Psychiatry 1982;5:319-29.
24. Clayton EW, Ross LF. Implications of disclosing individual results of clinical research. JAMA 2006;295:37.
25. Kimmelman J. The therapeutic misconception at 25: treatment, research, and confusion. Hastings Cent Rep 2007;37:36-42.